Skip to main content

Vaxart, Inc.

corporate_fare Company Profile

Vaxart, Inc.

VXRT·OTC·Life Sciences·CIK 0000072444

Vaxart, Inc. is a clinical-stage biotechnology company that develops oral recombinant vaccines. The company's primary focus is on its proprietary oral vaccine platform called Vector-Adjuvant-Antigen Standardized Technology ("VAAST"). Vaxart is developing prophylactic vaccine candidates for infectious diseases such as norovirus, coronavirus (including SARS-CoV-2, which causes COVID-19), and influenza. Additionally, the company has generated preclinical data for a therapeutic vaccine candidate aimed at cervical cancer and dysplasia caused by human papillomavirus ("HPV"). Vaxart's oral tablet vaccine candidates are designed to produce broad and lasting immune responses, including systemic, mucosal, and T cell responses, which may offer enhanced protection against certain infectious diseases and potential clinical benefits for some cancers and chronic viral infections like HPV. These tablet vaccines are also intended to provide a more efficient and convenient administration method, improve patient acceptance, and reduce distribution challenges, potentially enhancing the effectiveness of vaccination campaigns. The company's platform technology uses a vector-based approach, where a virus acts as a carrier to deliver DNA coding for vaccine antigens and an adjuvant selected to activate the immune system. Vaxart was originally incorporated in California in March 2004 as West Coast Biologicals, Inc., reincorporated in Delaware in July 2007 as Vaxart, Inc. ("Private Vaxart"), and completed a reverse merger with Aviragen Therapeutics, Inc. on February 13, 2018.

Vaxart, Inc. (OTC:VXRT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 42 items for VXRT at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Vaxart Files Definitive Proxy Materials, Urges Shareholders to Vote for Current Directors Amid Proxy Contest
  • Vaxart Files Definitive Proxy Materials, Urges Shareholder Support Against Dissident Nominees
  • Vaxart Files Definitive Proxy Statement for Contested Director Election
  • Vaxart Files Revised Proxy Statement, Intensifying Board Battle Against Activist Nominees
  • Activist Shareholders Launch Proxy Contest to Elect 3 Directors, Citing Value Destruction

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$237.26M
Net Income
$16.33M
Diluted EPS
$0.07
Op. Cash Flow
$7.71M
Free Cash Flow
$7.57M
Operating Income
$18.07M
Cash & Equivalents
$53.81M
Debt / Equity
0.00×
Net Margin
6.9%
Shares Outstanding
240.49M sh
Source: 10-K · filed 2026-04-30 · accession 0001437749-26-014245
$0.355 -1.39% today
52-week range · as of 2026-11-05 $0.32 – $0.8449
Market cap
$79.89M
Volume
744.8K (2.4× avg)
3-mo avg 315.9K
Live data · 2026-11-22 12:45 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed VXRT - Filings & News (Page 2)

VXRT
Jun 01, 2026, 5:10 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $0.630
Real-time Price: $0.355 info
Change: -$0.275 (-44%) info
Market Cap: $79.886M info
VXRT
Jun 01, 2026, 8:35 AM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $0.6558
Real-time Price: $0.355 info
Change: -$0.3008 (-46%) info
Market Cap: $79.886M info
VXRT
Jun 01, 2026, 8:14 AM EDT
Filing Type: DEFC14A
Importance Score:
8
Price at Filing: $0.6558
Real-time Price: $0.355 info
Change: -$0.3008 (-46%) info
Market Cap: $79.886M info
VXRT
May 29, 2026, 5:03 PM EDT
Filing Type: PRER14A
Importance Score:
8
Price at Filing: $0.645
Real-time Price: $0.355 info
Change: -$0.290 (-45%) info
Market Cap: $79.886M info
VXRT
May 29, 2026, 4:48 PM EDT
Filing Type: PRRN14A
Importance Score:
8
Price at Filing: $0.645
Real-time Price: $0.355 info
Change: -$0.290 (-45%) info
Market Cap: $79.886M info
VXRT
May 21, 2026, 5:21 PM EDT
Filing Type: PREC14A
Importance Score:
9
Price at Filing: $0.67911
Real-time Price: $0.355 info
Change: -$0.32411 (-48%) info
Market Cap: $79.886M info
VXRT
May 20, 2026, 7:24 AM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $0.610
Real-time Price: $0.355 info
Change: -$0.255 (-42%) info
Market Cap: $79.886M info
VXRT
May 19, 2026, 5:25 PM EDT
Filing Type: PREC14A
Importance Score:
9
Price at Filing: $0.610
Real-time Price: $0.355 info
Change: -$0.255 (-42%) info
Market Cap: $79.886M info
VXRT
May 19, 2026, 5:19 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $0.610
Real-time Price: $0.355 info
Change: -$0.255 (-42%) info
Market Cap: $79.886M info
VXRT
May 19, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.610
Real-time Price: $0.355 info
Change: -$0.255 (-42%) info
Market Cap: $79.886M info
VXRT
May 19, 2026, 4:55 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $0.610
Real-time Price: $0.355 info
Change: -$0.255 (-42%) info
Market Cap: $79.886M info
VXRT
May 19, 2026, 4:30 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.610
Real-time Price: $0.355 info
Change: -$0.255 (-42%) info
Market Cap: $79.886M info
VXRT
May 08, 2026, 5:30 PM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $0.700
Real-time Price: $0.355 info
Change: -$0.345 (-49%) info
Market Cap: $79.886M info
VXRT
May 07, 2026, 4:25 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.740
Real-time Price: $0.355 info
Change: -$0.385 (-52%) info
Market Cap: $79.886M info
VXRT
May 07, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.740
Real-time Price: $0.355 info
Change: -$0.385 (-52%) info
Market Cap: $79.886M info
VXRT
May 04, 2026, 5:29 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $0.75775
Real-time Price: $0.355 info
Change: -$0.40275 (-53%) info
Market Cap: $79.886M info
VXRT
Apr 23, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7399
Real-time Price: $0.355 info
Change: -$0.3849 (-52%) info
Market Cap: $79.886M info
VXRT
Apr 21, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7599
Real-time Price: $0.355 info
Change: -$0.4049 (-53%) info
Market Cap: $79.886M info
VXRT
Apr 17, 2026, 8:33 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.7388
Real-time Price: $0.355 info
Change: -$0.3838 (-52%) info
Market Cap: $79.886M info
VXRT
Apr 17, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7388
Real-time Price: $0.355 info
Change: -$0.3838 (-52%) info
Market Cap: $79.886M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets